{"id":399859,"date":"2020-12-15T08:33:09","date_gmt":"2020-12-15T13:33:09","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=399859"},"modified":"2020-12-15T08:33:09","modified_gmt":"2020-12-15T13:33:09","slug":"grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\/","title":{"rendered":"Grey Cloak Tech Inc. Subsidiary BergaMet NA\u2122 Announces Sales Agreement with Major Key Account, Xymogen\u00ae"},"content":{"rendered":"

\nXymogen\u00ae is a leading manufacturer and distributor of clinical grade nutraceuticals and ranked among the nation\u2019s fastest-growing privately held companies
\n<\/h2>\n
\n

LAS VEGAS, Dec. 15, 2020 (GLOBE NEWSWIRE) — Grey Cloak Tech Inc. (<\/strong>OTCQB: <\/strong>GRCK<\/strong><\/a> \u2013 name change pending to Healthy Extracts Inc.), a company engaged in the proprietary development of natural plant-based formulations as well as sales and distribution of cardiovascular and neuro products, today announces its subsidiary B<\/a>ergaMet<\/a> NA<\/a> has entered into an exclusive performance-driven agreement with Xymogen<\/a>\u00ae<\/sup><\/a> to purchase BergaMet\u2019s<\/a>Citrus Bergamot <\/a>SuperFruit<\/a>\u2122<\/a>.<\/p>\n

This agreement has been three years in development and Xymogen is now selling and distributing its proprietary formulations of BergaCor\u2122<\/a>\u00a0and BergaCorPlus\u2122<\/a>\u00a0to their 20,000- plus medical doctor network.<\/p>\n

\u201cBergaCor\u2122\u00a0and BergaCorPlus\u2122\u00a0are a top product release of 2020,\u201d stated Xymogen\u2019s President Brian Blackburn. \u201cThe BergaMet NA Citrus Bergamot SuperFruit\u2122\u00a0allows us to provide our Doctor Network with the highest quality and concentration of BPF (bergamot polyphenolic fraction) at 47%. Our natural BergaCor\u2122\u00a0products are specifically formulated to combat cardiovascular disease, metabolic syndrome and nonalcoholic fatty liver disease. We anticipate BergaCor\u2122\u00a0will be a core product for Xymogen for years to come.\u201d<\/p>\n

\u201cThis partnership with Xymogen exemplifies Bergamet NA\u2019s strategic B2B goal of a continued growth strategy,\u201d said Duke Pitts, president of BergaMet NA. \u201cWe are very excited as this agreement provides significant revenue generation and distribution through Xymogen\u2019s national market footprint. Xymogen also sells our recently introduced CLINICAL IMMUNE\u2122<\/a>\u00a0and we anticipate introducing new products as they become available.\u201d<\/p>\n

\u201cThis is a tremendous expansion for our Citrus Bergamot SuperFruit which we believe will be both catalytic to product awareness and brand while being highly accretive to our bottom line,\u201d added Pitts.<\/p>\n

BergaCor\u2122\u00a0and BergaCor Plus\u2122\u00a0is currently being sold\u00a0through www.xymogen.com<\/a>, www.wholescripts.com<\/a> and select doctors throughout the United States.<\/p>\n

\n About Grey Cloak Tech Inc. <\/strong>
\n
Grey Cloak Tech Inc. (OTCQB: GRCK \u2013 name change pending to Healthy Extracts Inc.), through its two subsidiaries, BergaMet NA and Ultimate Brain Nutrients (\u201cUBN\u201d), is engaged in proprietary research and development of natural plant-based formulations, as well as sales and distribution of natural ingredient cardiovascular and neuro products. For more information, visit the company\u2019s websites:<\/p>\n

\n www.HealthyExtractsinc.com<\/a>, www.GreyCloakTech.com<\/a>,\u00a0www.BergametNA.com<\/a>,\u00a0
www.UBNutrients.com<\/a>.<\/p>\n

\n About BergaMet NA<\/strong>
\n
BergaMet NA, a wholly owned subsidiary of Grey Cloak Technologies (OTC: GRCK), is a provider of nutraceutical natural heart health supplements. Based in Nevada, BergaMet researches and develops proprietary, natural, plant-based formulations. BergaMet also provides sales and distribution of natural neuro products that feature superior health technologies based on clinical and doctor-supported evidence for maintaining a healthy immune system and improving the metabolic syndrome. Learn more at www.BergametNA.com<\/a>.<\/p>\n

\n Forward-Looking Statements and Safe Harbor Notice<\/strong>
\n
All statements other than statements of historical facts included in this press release are \u201cforward-looking statements\u201d (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as \u201cprojected,\u201d \u201cexpect,\u201d “possibility\u201d and \u201canticipate.\u201d The achievement or success of the matters covered by such forward-looking statements involves significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company\u2019s Annual Report on Form 10-K filed with the SEC on April 1, 2020, and future periodic reports filed with the SEC. All of the Company\u2019s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.
The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.<\/p>\n

\n Grey Cloak Tech Inc.:<\/strong>
\n
\n info@GreyCloakTech.com<\/a>\n <\/p>\n

\n Corporate Communications:<\/strong>
\n
\n Las Vegas, Nevada<\/strong>
\n
\n www.healthyextractsinc.com<\/a>
\n
\n info@healthyextractsinc.com<\/a>
\n
720-463-1004<\/p>\n<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Xymogen\u00ae is a leading manufacturer and distributor of clinical grade nutraceuticals and ranked among the nation\u2019s fastest-growing privately held companies LAS VEGAS, Dec. 15, 2020 (GLOBE NEWSWIRE) — Grey Cloak Tech Inc. (OTCQB: GRCK \u2013 name change pending to Healthy Extracts Inc.), a company engaged in the proprietary development of natural plant-based formulations as well as sales and distribution of cardiovascular and neuro products, today announces its subsidiary BergaMet NA has entered into an exclusive performance-driven agreement with Xymogen\u00ae to purchase BergaMet\u2019sCitrus Bergamot SuperFruit\u2122. This agreement has been three years in development and Xymogen is now selling and distributing its proprietary formulations of BergaCor\u2122\u00a0and BergaCorPlus\u2122\u00a0to their 20,000- plus medical doctor network. \u201cBergaCor\u2122\u00a0and BergaCorPlus\u2122\u00a0are a top product release of 2020,\u201d stated … <\/p>\n

Continue reading “Grey Cloak Tech Inc. Subsidiary BergaMet NA\u2122 Announces Sales Agreement with Major Key Account, Xymogen\u00ae”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-399859","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nGrey Cloak Tech Inc. Subsidiary BergaMet NA\u2122 Announces Sales Agreement with Major Key Account, Xymogen\u00ae - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Grey Cloak Tech Inc. Subsidiary BergaMet NA\u2122 Announces Sales Agreement with Major Key Account, Xymogen\u00ae - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Xymogen\u00ae is a leading manufacturer and distributor of clinical grade nutraceuticals and ranked among the nation\u2019s fastest-growing privately held companies LAS VEGAS, Dec. 15, 2020 (GLOBE NEWSWIRE) — Grey Cloak Tech Inc. (OTCQB: GRCK \u2013 name change pending to Healthy Extracts Inc.), a company engaged in the proprietary development of natural plant-based formulations as well as sales and distribution of cardiovascular and neuro products, today announces its subsidiary BergaMet NA has entered into an exclusive performance-driven agreement with Xymogen\u00ae to purchase BergaMet\u2019sCitrus Bergamot SuperFruit\u2122. This agreement has been three years in development and Xymogen is now selling and distributing its proprietary formulations of BergaCor\u2122\u00a0and BergaCorPlus\u2122\u00a0to their 20,000- plus medical doctor network. \u201cBergaCor\u2122\u00a0and BergaCorPlus\u2122\u00a0are a top product release of 2020,\u201d stated … Continue reading "Grey Cloak Tech Inc. Subsidiary BergaMet NA\u2122 Announces Sales Agreement with Major Key Account, Xymogen\u00ae"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-15T13:33:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMjIyOCMzODgxNTY1IzUwMDA3NjQ0MQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Grey Cloak Tech Inc. Subsidiary BergaMet NA\u2122 Announces Sales Agreement with Major Key Account, Xymogen\u00ae\",\"datePublished\":\"2020-12-15T13:33:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\\\/\"},\"wordCount\":682,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMjIyOCMzODgxNTY1IzUwMDA3NjQ0MQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\\\/\",\"name\":\"Grey Cloak Tech Inc. Subsidiary BergaMet NA\u2122 Announces Sales Agreement with Major Key Account, Xymogen\u00ae - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMjIyOCMzODgxNTY1IzUwMDA3NjQ0MQ==\",\"datePublished\":\"2020-12-15T13:33:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMjIyOCMzODgxNTY1IzUwMDA3NjQ0MQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMjIyOCMzODgxNTY1IzUwMDA3NjQ0MQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Grey Cloak Tech Inc. Subsidiary BergaMet NA\u2122 Announces Sales Agreement with Major Key Account, Xymogen\u00ae\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Grey Cloak Tech Inc. Subsidiary BergaMet NA\u2122 Announces Sales Agreement with Major Key Account, Xymogen\u00ae - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\/","og_locale":"en_US","og_type":"article","og_title":"Grey Cloak Tech Inc. Subsidiary BergaMet NA\u2122 Announces Sales Agreement with Major Key Account, Xymogen\u00ae - Market Newsdesk","og_description":"Xymogen\u00ae is a leading manufacturer and distributor of clinical grade nutraceuticals and ranked among the nation\u2019s fastest-growing privately held companies LAS VEGAS, Dec. 15, 2020 (GLOBE NEWSWIRE) — Grey Cloak Tech Inc. (OTCQB: GRCK \u2013 name change pending to Healthy Extracts Inc.), a company engaged in the proprietary development of natural plant-based formulations as well as sales and distribution of cardiovascular and neuro products, today announces its subsidiary BergaMet NA has entered into an exclusive performance-driven agreement with Xymogen\u00ae to purchase BergaMet\u2019sCitrus Bergamot SuperFruit\u2122. This agreement has been three years in development and Xymogen is now selling and distributing its proprietary formulations of BergaCor\u2122\u00a0and BergaCorPlus\u2122\u00a0to their 20,000- plus medical doctor network. \u201cBergaCor\u2122\u00a0and BergaCorPlus\u2122\u00a0are a top product release of 2020,\u201d stated … Continue reading \"Grey Cloak Tech Inc. Subsidiary BergaMet NA\u2122 Announces Sales Agreement with Major Key Account, Xymogen\u00ae\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-15T13:33:09+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMjIyOCMzODgxNTY1IzUwMDA3NjQ0MQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Grey Cloak Tech Inc. Subsidiary BergaMet NA\u2122 Announces Sales Agreement with Major Key Account, Xymogen\u00ae","datePublished":"2020-12-15T13:33:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\/"},"wordCount":682,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMjIyOCMzODgxNTY1IzUwMDA3NjQ0MQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\/","name":"Grey Cloak Tech Inc. Subsidiary BergaMet NA\u2122 Announces Sales Agreement with Major Key Account, Xymogen\u00ae - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMjIyOCMzODgxNTY1IzUwMDA3NjQ0MQ==","datePublished":"2020-12-15T13:33:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMjIyOCMzODgxNTY1IzUwMDA3NjQ0MQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMjIyOCMzODgxNTY1IzUwMDA3NjQ0MQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/grey-cloak-tech-inc-subsidiary-bergamet-na-announces-sales-agreement-with-major-key-account-xymogen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Grey Cloak Tech Inc. Subsidiary BergaMet NA\u2122 Announces Sales Agreement with Major Key Account, Xymogen\u00ae"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/399859","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=399859"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/399859\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=399859"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=399859"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=399859"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}